Skip to main content
. 2022 Aug 18;12:14090. doi: 10.1038/s41598-022-18136-5

Table 2.

Outcomes of CT-guided percutaneous radiofrequency ablation.

Outcomes
Mortality 0%
Intraprocedural hypertension over 180 mmHg 43.2%
Adverse events
Grade 3 26.3%
Grade 4 2.6%
Grade 5 0%
Treatment success rate
Percentage of complete tumor ablation on CT scan, (%) 94.6%
Percentage of aldosterone normalization rate at 84 days, (%) 86.5%
The number of types of antihypertensive drugs
Day 0 1.6 ± 1.3
Day 84 0.5 ± 0.7

CT Computed tomography.